| Serial Number | 90879588 |
| Word Mark | SIMLANDI (ADALIMUMAB-XXXX) INJECTION |
| Filing Date | Thursday, August 12, 2021 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Monday, November 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 18, 2022 |
| Description of Mark | The mark consists of two stylized rhombus designs, the left is sky blue and the right is burgundy. To the right of the stylized rhombus designs appears the wording "SIMLANDI" written in burgundy stylized text. Beneath the wording "SIMLANDI" appears the wording "(ADALIMUMAB-XXXX)" written in black stylized font. Beneath the wording "(ADALIMUMAB-XXXX)" appears the wording "INJECTION" written in black stylized font. |
| Goods and Services | Pharmaceutical preparations featuring monoclonal antibodies for the treatment of autoimmune diseases |
| Indication of Colors claimed | The color(s) sky blue, burgundy and black is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "(ADALIMUMAB-XXXX) INJECTION" |
| Goods and Services | Injectors for medical purposes, namely, medical fluid injectors |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 4, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, January 1, 2024 |
| First Use In Commerce Date | Monday, January 1, 2024 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 4, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | Monday, January 1, 2024 |
| First Use In Commerce Date | Monday, January 1, 2024 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Tuesday, October 5, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, August 16, 2021 | NEW APPLICATION ENTERED |
| Monday, October 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 12, 2021 | ASSIGNED TO EXAMINER |
| Thursday, November 18, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 18, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 18, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 18, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 18, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 30, 2021 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Tuesday, December 7, 2021 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, December 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 10, 2021 | ASSIGNED TO LIE |
| Saturday, December 11, 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, January 18, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 29, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, September 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 18, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 15, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 6, 2023 | SOU EXTENSION 2 FILED |
| Thursday, September 15, 2022 | SOU EXTENSION 1 FILED |
| Thursday, September 15, 2022 | SOU EXTENSION 1 GRANTED |
| Saturday, September 17, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 6, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 6, 2023 | SOU EXTENSION 2 GRANTED |
| Wednesday, March 8, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 12, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 13, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 12, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, September 12, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, March 13, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, March 13, 2024 | SOU EXTENSION 4 GRANTED |
| Thursday, March 14, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 30, 2024 | USE AMENDMENT FILED |
| Friday, August 30, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Friday, November 1, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, November 1, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, November 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, November 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 4, 2024 | SU - NON-FINAL ACTION - WRITTEN |